Massive study tracks Real-World weight loss after popular obesity drug
NCT ID NCT07423481
Summary
This study aims to understand what happens to people's weight over time after they stop or change their treatment with the obesity medication semaglutide (Wegovy). Researchers will follow 3,000 patients in France with severe obesity to see how their weight changes and identify which patient characteristics predict better long-term results. The study collects real-world data from patients who received the medication through a special access program.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nantes university hospital
Nantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.